Crohns & Colitis 360

Scope & Guideline

Innovating gastroenterology through open access research.

Introduction

Welcome to the Crohns & Colitis 360 information hub, where our guidelines provide a wealth of knowledge about the journal’s focus and academic contributions. This page includes an extensive look at the aims and scope of Crohns & Colitis 360, highlighting trending and emerging areas of study. We also examine declining topics to offer insight into academic interest shifts. Our curated list of highly cited topics and recent publications is part of our effort to guide scholars, using these guidelines to stay ahead in their research endeavors.
LanguageEnglish
ISSN-
PublisherOXFORD UNIV PRESS
Support Open AccessNo
Country-
Type-
Converge-
AbbreviationCROHNS COLITIS 360 / Crohns Colitis 360
Frequency4 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressGREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND

Aims and Scopes

The journal 'Crohns & Colitis 360' focuses on advancing the understanding and management of inflammatory bowel disease (IBD), particularly Crohn's disease and ulcerative colitis. Its research encompasses a variety of methodologies, including clinical studies, systematic reviews, and qualitative research, aimed at improving patient outcomes through evidence-based practices.
  1. Clinical Management of IBD:
    Research aimed at optimizing treatment pathways, medication adherence, and clinical decision-making in the management of Crohn's disease and ulcerative colitis.
  2. Patient-Centric Research:
    Studies focusing on patient experiences, perspectives, and quality of life related to IBD, emphasizing the importance of patient engagement in treatment decisions.
  3. Innovative Therapeutics:
    Exploration of new therapeutic agents, including biologics and small molecules, and their efficacy, safety, and long-term outcomes in IBD treatment.
  4. Epidemiological and Health Economic Studies:
    Research investigating the prevalence, healthcare costs, and economic burden of IBD, providing insights into the broader impact of these diseases on healthcare systems.
  5. Use of Technology in IBD Management:
    Utilization of artificial intelligence, machine learning, and telehealth to enhance diagnostic accuracy, treatment adherence, and patient monitoring.
  6. Nutritional and Dietary Interventions:
    Exploration of the role of diet and nutrition in managing IBD symptoms and improving patient outcomes, including the effectiveness of dietary therapies.
Recent publications in 'Crohns & Colitis 360' indicate several emerging and trending themes that reflect the evolving landscape of IBD research. This section outlines these key areas of focus that are gaining traction.
  1. Real-World Evidence and Patient Outcomes:
    There is a growing emphasis on real-world studies that assess treatment effectiveness and patient-reported outcomes, highlighting the importance of understanding therapy impacts in everyday clinical settings.
  2. Telehealth and Remote Monitoring:
    Research exploring telehealth solutions and remote patient monitoring technologies is on the rise, especially in the context of increasing patient needs for accessible care and management during the COVID-19 pandemic.
  3. Psychosocial Factors in IBD:
    Emerging studies focus on the psychosocial aspects of living with IBD, including the impact of mental health on disease management and the importance of addressing psychological comorbidities.
  4. Diversity and Health Disparities:
    There is an increasing awareness and study of racial, ethnic, and geographic disparities in IBD care and outcomes, emphasizing the need for equitable healthcare access.
  5. Dietary Interventions and Personalized Nutrition:
    Research into dietary therapies and their role in managing IBD symptoms is expanding, with a focus on personalized nutritional approaches tailored to individual patient needs.

Declining or Waning

While many themes continue to thrive within 'Crohns & Colitis 360', certain areas of research appear to be waning in prominence. This section highlights those themes that are increasingly less represented in recent publications.
  1. Traditional Pharmacotherapy:
    Research focused exclusively on conventional medications for IBD, such as corticosteroids and thiopurines, seems to be declining as newer therapies gain attention.
  2. Surgical Interventions:
    The volume of studies addressing surgical management of IBD, including colectomies and resections, is decreasing, possibly due to a shift towards medical management and minimally invasive techniques.
  3. Basic Science and Mechanistic Studies:
    There is less emphasis on basic science research exploring the underlying mechanisms of IBD, as the journal increasingly prioritizes clinical and translational research.
  4. Single-Center Studies:
    The prevalence of single-center studies is diminishing in favor of multicenter collaborations that provide broader data and insights into IBD management.
  5. Conventional Epidemiological Studies:
    Traditional epidemiological research focusing solely on demographic trends in IBD without integrating patient-reported outcomes or economic evaluations appears to be less frequent.

Similar Journals

Minerva Gastroenterology

Elevating Clinical Practices with Cutting-Edge Insights
Publisher: EDIZIONI MINERVA MEDICAISSN: 2724-5985Frequency: 4 issues/year

Minerva Gastroenterology, published by EDIZIONI MINERVA MEDICA, is a notable academic journal dedicated to advancing the field of gastroenterology and related disciplines. With an ISSN of 2724-5985 and an E-ISSN of 2724-5365, this journal gathers innovative research from diverse areas including internal medicine, endocrinology, and metabolism. Though characterized by its open-access policies, Minerva Gastroenterology aims to provide a platform for high-quality scholarly articles with an emphasis on critical reviews, clinical studies, and translational research. Since its inception in 2021, the journal has managed to secure a reputation reflected in its Q3 rank across multiple categories in 2023, as well as its standing in Scopus rankings, positioning it in the 45th to 47th percentile among renowned medical journals. Situated in Turin, Italy, it fosters collaboration and knowledge-sharing among researchers and practitioners, making it an essential resource for those seeking to deepen their understanding of gastroenterological conditions and enhance clinical practices.

Nature Reviews Gastroenterology & Hepatology

Synthesis of Cutting-Edge Research and Clinical Insights
Publisher: NATURE PORTFOLIOISSN: 1759-5045Frequency: 12 issues/year

Nature Reviews Gastroenterology & Hepatology is a premier academic journal published by NATURE PORTFOLIO, specializing in the vital fields of gastroenterology and hepatology. With an impressive impact factor and categorized in Q1 for both disciplines, this journal ranks at the top of its field, with Scopus rankings placing it in the 99th percentile for gastroenterology and hepatology. The journal aims to provide critical reviews that synthesize the latest research findings, clinical practices, and breakthroughs, catering to researchers, healthcare professionals, and students alike. With its wide-ranging access options, it promotes the dissemination of knowledge essential for advancements in understanding digestive and liver disorders. The journal has been committed to academic excellence since its convergence in 2009, continuing to shape the future of gastroenterological and hepatological research through rigorous peer-reviewed content.

Therapeutic Advances in Gastroenterology

Leading the charge in gastrointestinal advancements.
Publisher: SAGE PUBLICATIONS LTDISSN: 1756-283XFrequency: 1 issue/year

Therapeutic Advances in Gastroenterology, published by SAGE Publications Ltd, is a premier open access journal dedicated to the advancement of knowledge in the field of gastroenterology. Since its inception in 2008 and its transition to open access in 2018, the journal has consistently provided high-quality peer-reviewed research articles, review papers, and clinical studies that address the latest therapeutic advancements and challenges in gastrointestinal medicine. With an impressive impact factor and a 2023 Scopus ranking placing it in the Q1 quartile of gastroenterology journals, it stands as a leading platform for researchers, clinicians, and healthcare professionals. The journal’s commitment to disseminating impactful research has positioned it at the forefront of academic discourse, offering a vital resource for those devoted to improving patient outcomes in digestive health. The United Kingdom-based journal invites submissions that contribute to the understanding and treatment of gastrointestinal disorders, ensuring that cutting-edge findings reach a global audience.

DISEASES OF THE COLON & RECTUM

Elevating Standards in Digestive Health Research
Publisher: LIPPINCOTT WILLIAMS & WILKINSISSN: 0012-3706Frequency: 12 issues/year

DISEASES OF THE COLON & RECTUM, published by Lippincott Williams & Wilkins, stands as a critical resource in the field of gastroenterology, focusing on the comprehensive study and management of colorectal diseases. With an ISSN of 0012-3706 and an E-ISSN of 1530-0358, this journal serves a diverse audience, including researchers, clinicians, and students interested in the latest advancements in this vital area of medicine. Recognized for its quality, it holds a Q2 ranking in both Gastroenterology and Miscellaneous Medicine categories for 2023 and is positioned at the 58th percentile within its Scopus rank. Since its inception in 1958, the journal has dedicated itself to disseminating original research, reviews, and clinical studies, providing a platform for sharing innovative findings that drive the field forward. While it is not an open access journal, its content remains pivotal for professionals looking to stay apprised of evidence-based practices and emerging trends in colorectal health. With ongoing contributions expected until 2024, DISEASES OF THE COLON & RECTUM continues to be an indispensable source of knowledge for anyone engaged in the intricacies of digestive health.

Frontline Gastroenterology

Championing Excellence in Gastroenterological Research
Publisher: BMJ PUBLISHING GROUPISSN: 2041-4137Frequency: 4 issues/year

Frontline Gastroenterology is a leading academic journal published by the BMJ Publishing Group that plays a vital role in advancing the field of gastroenterology and hepatology. Established in 2013, this prestigious journal has established itself as a significant resource for researchers, healthcare professionals, and students alike, maintaining a commendable impact factor and consistently achieving a Q2 ranking in both gastroenterology and hepatology categories as of 2023. With its focus on disseminating high-quality, peer-reviewed research, Frontline Gastroenterology covers a wide scope of topics pertinent to the understanding, diagnosis, and treatment of gastrointestinal and liver diseases. Although it does not offer Open Access options, its content is accessible through various institutional and personal subscriptions, ensuring that critical findings reach an international audience. As the journal continues to converge into the future, it remains dedicated to fostering innovation and dialogue in gastroenterological sciences.

DIGESTIVE AND LIVER DISEASE

Transforming the landscape of liver disease research.
Publisher: ELSEVIER SCIENCE INCISSN: 1590-8658Frequency: 12 issues/year

DIGESTIVE AND LIVER DISEASE is a prominent journal published by Elsevier Science Inc, dedicated to advancing the field of gastroenterology and hepatology. With an ISSN of 1590-8658 and an E-ISSN of 1878-3562, this journal has established itself as a significant resource within the academic community, especially considering its Q2 ranking in both gastroenterology and hepatology categories as of 2023. Spanning from 2000 to 2024, the journal presents a diverse array of peer-reviewed articles, clinical studies, and review papers that explore the latest advancements and research findings in digestive and liver diseases. The journal's robust impact, reflected in its Scopus rankings—40th out of 167 in gastroenterology and 28th out of 82 in hepatology—highlights its critical role in shaping practices and understanding in these vital areas of medicine. With open access options available, DIGESTIVE AND LIVER DISEASE aims to make high-quality research accessible to a wider audience, thereby encouraging collaboration and innovation. Researchers, healthcare professionals, and students alike will find valuable insights into the complex mechanisms, diagnostics, and therapeutic strategies pertinent to digestive and liver health.

Gastroenterology Research

Fostering collaboration in the pursuit of gastrointestinal health.
Publisher: ELMER PRESS INCISSN: 1918-2805Frequency: 6 issues/year

Gastroenterology Research is a prominent scholarly journal dedicated to advancing the field of gastroenterology. Published by ELMER PRESS INC, this journal serves as a vital platform for disseminating innovative research, clinical findings, and comprehensive reviews that explore the complexities of the gastrointestinal system. With an ISSN of 1918-2805 and an E-ISSN of 1918-2813, it reaches a global audience of researchers, healthcare professionals, and students eager to contribute to or keep abreast of the latest developments in gastroenterology. Though details such as the H-index and Scopus rankings are currently unspecified, the journal's commitment to quality and impact in the medical research community is evident. Gastroenterology Research aims to foster collaboration and knowledge sharing among experts, ultimately improving patient care and outcomes within this critical area of health science. Explore the cutting-edge studies published within its pages and engage with a community passionate about the investigation and treatment of gastrointestinal diseases.

DIGESTION

Advancing gastroenterology through rigorous research.
Publisher: KARGERISSN: 0012-2823Frequency: 6 issues/year

DIGESTION is a prestigious journal dedicated to advancing the field of gastroenterology, published by KARGER, a renowned publisher based in Switzerland. With a rich history dating back to 1896, this journal has continuously evolved and serves as a vital platform for researchers, professionals, and students alike. DIGESTION is recognized for its scholarly contributions, holding an impressive rank of 23 out of 167 in the Scopus database, placing it within the top 14% of gastroenterology journals, as evidenced by its Q2 classification. The journal's commitment to high-quality research is reflected in its wide-ranging scope, addressing various aspects of digestive health, clinical practices, and innovative therapies. Though not an open-access journal, it provides comprehensive access options that ensure the dissemination of crucial research findings to the global community. As we move towards 2024, DIGESTION continues to facilitate dialogue and insights in gastroenterological research, making it an indispensable resource for those in the field.

Saudi Journal of Gastroenterology

Connecting researchers to the latest in gastroenterology.
Publisher: WOLTERS KLUWER MEDKNOW PUBLICATIONSISSN: 1319-3767Frequency: 6 issues/year

The Saudi Journal of Gastroenterology is a premier platform dedicated to advancing research and clinical practice in the field of gastroenterology. Published by Wolters Kluwer Medknow Publications, this open-access journal has been serving the academic community since 1995 from its base in India. With an ISSN of 1319-3767 and an E-ISSN of 1998-4049, the journal allows unrestricted access to a wealth of knowledge, fostering an environment where researchers, professionals, and students can engage with cutting-edge studies. As of 2023, it is categorized in the Q3 quartile within gastroenterology, ranking #74 out of 167 in Scopus, which places it within the 55th percentile of its field. The journal aims to disseminate significant findings, clinical trials, and innovative theories that shape the understanding of gastrointestinal disorders and practices. With a commitment to quality and relevance, the Saudi Journal of Gastroenterology is pivotal for anyone seeking to enhance their knowledge and expertise in this vital area of medicine.

JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION

Innovating approaches to pediatric gastrointestinal health.
Publisher: WILEYISSN: 0277-2116Frequency: 12 issues/year

Journal of Pediatric Gastroenterology and Nutrition is a premier academic journal published by Wiley, focusing on the critical intersection of pediatric gastroenterology and nutrition. Established in 1982, this journal has been at the forefront of research and clinical practices for over four decades and continues to contribute invaluable insights to the fields of pediatrics and gastrointestinal health, boasting a Q1 ranking in Pediatrics, Perinatology and Child Health and a Q2 ranking in Gastroenterology as of 2023. The journal features a comprehensive array of original research, review articles, and clinical studies aimed at improving the understanding and management of pediatric gastrointestinal disorders and nutrient imbalances. Edited with expertise, the Journal of Pediatric Gastroenterology and Nutrition serves as an essential resource for clinicians, researchers, and students dedicated to advancing the well-being of children with digestive health issues. Readers can access the journal's impactful research studies through traditional subscriptions.